Thanks for sharing the article. I couldn’t open the original link, but I found it on the AFR.
The commentary was positive. She mentioned Bubs is in a strong position right now. US FDA approval is progressing, well and with about half of Bubs’ revenue coming from the US, that’s a major tailwind for growth.
It’s disappointing she didn’t mention China growth (it’s now half of US revenues) or the recent win against alpha group which $26M was awarded to bubs.
Hopefully, the silence is due to regulatory constraints and a formal market update is on the way
Thanks for sharing the article. I couldn’t open the original...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $142.9M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 15.8¢ | $240.2K | 1.490M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 404981 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 82249 | 7 |
View Market Depth
| Last trade - 16.15pm 30/07/2025 (20 minute delay) ? |
| BUB (ASX) Chart |